Byetta is part of the incretin mimetic class of medications and simulates the role of incretin in the body. By stimulating the pancreas to produce more insulin, Byetta has successfully helped many patients living with type 2 diabetes to better manage their blood sugar levels. However, the drug has allegedly been linked to an increased risk of serious and life-threatening health conditions such as thyroid cancer, pancreatic cancer, pancreatitis and kidney failure.
If you would like more information about filing a Mississippi Byetta lawsuit, contact an experienced attorney to determine whether you have a valid claim. If you were injured while taking the medication, you may be entitled to recover damages and hold the manufacturer responsible for your condition.
Byetta Background
Following the approval of Byetta, its manufacturer, Amylin Pharmaceuticals, claimed that patients would notice that their bodies were able to better use the insulin produced by the pancreas and find that they were better able to manage their blood glucose levels. However, those filing claims against the company allege that the manufacturer used aggressive marketing tactics to earn over $700 million between 2005 and 2008 when it had not yet been determined that the drug was safe. The U.S. Food and Drug Administration (FDA) did, however, approve it for use in April 2005.
Although the drug has helped many living with type 2 diabetes, you may be entitled to file a Mississippi Byetta lawsuit if you took the drug and subsequently suffered from adverse side effects or conditions. Contact an attorney to learn more about your legal rights.
Side Effects and Health Risks of Byetta
Byetta may increase a patient’s risk of developing pancreatic cancer six-fold, and those using the drug may be twice as likely to require hospitalization from pancreatitis as those taking other type 2 diabetes medications, according to adverse event reports submitted to the FDA and clinical trials.
If you or a loved one have suffered from any of the following symptoms or side effects, consider seeking legal counsel to file your Mississippi Byetta lawsuit and hold the manufacturer accountable for your injuries:
- Allergic reactions
- Immunogenicity
- Hypersensitivity
- Nausea
- Chest pain
- Vomiting
- Headache
- Kidney damage
- Hypoglycemia
- Renal impairment
Plaintiffs Allege Injuries
Since the number of plaintiffs filing claims pertaining to incretin mimetics appears to be increasing every month, the cases have been consolidated into a multidistrict litigation (MDL) to be held in the U.S. District Court, Southern District of California. Attorneys speculate that additional plaintiffs will come forward to join the proceeding within the next several months.
Byetta and other incretin mimetics such as Victoza, Januvia and Janumet allegedly cause cancer and other adverse health complications, according to pending lawsuits, and plaintiffs are seeking compensation to hold the manufacturers accountable for their alleged negligence.
Between September 2013 and October 2013, the number of claims increased from 60 to over 150, according to court documents. Three bellwether trials have been scheduled for 2014 and two will be held in 2015 in an attempt to provide both parties with an outlook on how additional claims will be settled in the future.
Filing a Mississippi Byetta Lawsuit Can Help You to Recover Damages
If you or a loved one are taking Byetta and you have been diagnosed with kidney failure, pancreatitis, pancreatic cancer, thyroid cancer or other adverse health condition, consider seeking legal counsel to file a Mississippi Byetta lawsuit. At Attorney Group for Mississippi, we can answer your questions and concerns to the best of our ability and provide you with a free case evaluation with no obligation. We will connect you with attorneys experienced in handling Mississippi Byetta lawsuits who will work to help you seek the compensation to which you may be entitled.
